Clinical Trial Update: Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and early signals of efficacy for cabozantinib and abiraterone combined with checkpoint inhibitor immunotherapy in metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone (abiraterone)
• cabozantinib (cabozantinib)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Metastatic Hormone Refractory Prostate Cancer | Phase 1 | Status: COMPLETED